re-irradiation
Showing 1 - 25 of 5,561
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Breast Cancer, Recurrent Trial in Meldola (Partial breast re-irradiation)
Not yet recruiting
- Breast Cancer
- Recurrent
- Partial breast re-irradiation
-
Meldola, Forlì Cesena, ItalyUO Radioterapia, IRST IRCCS
Mar 6, 2023
Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))
Recruiting
- Glioma
- Pulsed low dose-rate radiotherapy (pLDRT)
-
Aviano, Pordenone, ItalyIRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023
Rectal Cancer, Recurrent Trial in Shanghai (Carbon ion radiation therapy DT: 74Gy/20 fractions)
Not yet recruiting
- Rectal Cancer
- Recurrent
- Carbon ion radiation therapy DT: 74Gy/20 fractions
-
Shanghai, Pudong, ChinaShanghai Proton and Heavy ion center
Apr 7, 2023
Glioblastoma Trial in Strasbourg (Simultaneous-integrated boost with IMRT)
Not yet recruiting
- Glioblastoma
- Simultaneous-integrated boost with IMRT
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Dec 7, 2022
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Locally Advanced Head-and-Neck Cancer Trial in Heidelberg (C12 re-irradiation, Photon re-irradiation)
Recruiting
- Locally Advanced Head-and-Neck Cancer
- C12 re-irradiation
- Photon re-irradiation
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022
High Dose Re-Irradiation Utilizing Advanced Deformable Image
Not yet recruiting
- Solid Tumor
- Re-irradiation
- (no location specified)
Jun 13, 2022
Ependymoma Trial in Memphis, Toronto (radiation, procedure, drug, device)
Active, not recruiting
- Ependymoma
- Irradiation
- +5 more
-
Memphis, Tennessee
- +1 more
Oct 28, 2022
Breast Cancer, Breast Cancer Recurrent Trial (rPBI)
Not yet recruiting
- Breast Cancer
- Breast Cancer Recurrent
- rPBI
- (no location specified)
Oct 21, 2022
Cancer Patients Receiving Stereotactic Body RTX Trial in Dallas (SBRT)
Recruiting
- Cancer Patients Receiving Stereotactic Body RTX
- SBRT
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Aug 25, 2022
Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))
Not yet recruiting
- Recurrent Glioblastoma
- Niraparib
- Re-irradiation (re-RT)
- (no location specified)
Dec 23, 2022
Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation
Recruiting
- Tumor Recurrence
- +3 more
- carbon ion radiation therapy
-
Pavia, Pv, ItalyCNAO
Jul 13, 2022
Pancreatic Cancer Trial in Shanghai (Re-irradiation with SBRT)
Recruiting
- Pancreatic Cancer
- Re-irradiation with SBRT
-
Shanghai, Shanghai, ChinaHuojun Zhang
Jan 6, 2022
Rectal Cancer, Recurrence, Radiation Toxicity Trial in Aarhus, Oslo (Hyperfractionated external beam radiation)
Completed
- Rectal Cancer
- +2 more
- Hyperfractionated external beam radiation
-
Aarhus, Denmark
- +1 more
Apr 14, 2023
Cancer, Brain Metastases, Adult Trial in Copenhagen (Repeated stereotactic radiosurgery)
Recruiting
- Cancer
- Brain Metastases, Adult
- Repeated stereotactic radiosurgery
-
Copenhagen, DenmarkRigshospitalet, University of Copenhagen
Nov 8, 2021
Metastatic Spine Lesions Trial in New York (single-fraction radiation, MRI and/or CT)
Active, not recruiting
- Metastatic Spine Lesions
- single-fraction radiation
- MRI and/or CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 29, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Cetuximab, Stereotactic radiosurgery)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Cetuximab
- Stereotactic radiosurgery
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Feb 10, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- Stereotactic Body Radiation Therapy (SBRT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022
Glioma Trial in Madison (Bevacizumab, PRDR)
Recruiting
- Glioma
- Bevacizumab
- PRDR
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Nov 14, 2022
Recurrent Glioblastoma Trial in Taoyuan (NaviFUS System)
Recruiting
- Recurrent Glioblastoma
- NaviFUS System
-
Taoyuan, TaiwanChang Gung Medical Foundation
Sep 23, 2021
Recurrent or Progressive Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, New Zealand (re-irradiation)
Recruiting
- Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
- re-irradiation
-
Westmead, New South Wales, Australia
- +17 more
Dec 14, 2021
Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma, Chemo Effect Trial in Shanghai (Tislelizumab)
Recruiting
- Recurrent Nasopharyngeal Carcinoma
- +4 more
-
Shanghai, ChinaEye and ENT Hospital of Fudan University
Mar 23, 2022